Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glycolic acid review

This article was originally published in The Rose Sheet

Executive Summary

CTFA is asking the Cosmetic Ingredient Review (CIR) to hasten its consideration of the safety of glycolic acid because of FDA's concern regarding alpha hydroxy acids, particularly when used at high concentrations ("The Rose Sheet" April 11, p. 1). CTFA also is requesting that CIR look at the commonly used salts and esters of glycolic acid as well as citric and lactic acids and their salts and esters. CIR would have reviewed glycolic acid beginning in 1995
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS000466

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel